This is actually a really well-studied phenomenon. The short answer is: yes, people with T2DM tend to lose less weight on semaglutide than people without T2DM.
The data is pretty clear:
| Trial | Population | Dose | Mean Weight Loss (68 wks) |
|---|---|---|---|
| STEP 1 | Overweight/obese, no T2DM | 2.4mg | -14.9% |
| STEP 2 | Overweight/obese WITH T2DM | 2.4mg | -9.6% |
| STEP 2 | Overweight/obese WITH T2DM | 1.0mg | -7.0% |
| STEP 3 | Overweight/obese, no T2DM + IBT | 2.4mg | -16.0% |
So at the same 2.4mg dose, non-diabetics lost about 50% more weight than diabetics (14.9% vs 9.6%).[1][2]
Several reasons for this:
- Insulin effects: T2DM patients often have hyperinsulinemia. Insulin is an anabolic hormone that promotes fat storage. As semaglutide improves insulin sensitivity and reduces hyperinsulinemia, you'd think that would help with weight loss — but the metabolic correction itself means the body isn't wasting as many calories through glucosuria (peeing out glucose).
- Concomitant medications: Many T2DM patients are on sulfonylureas or insulin, which cause weight gain. This creates a pharmacological headwind.
- Metabolic adaptation: T2DM involves more profound metabolic derangement — insulin resistance affects adipose tissue metabolism, making it harder to mobilize fat stores.
- Dose differences: Your sister is on 1mg (Ozempic dose), you're on 1.7mg. That's a significant dose difference.
Tell your sister she's not doing anything wrong. The drug is working — it's just working on more things simultaneously in her body. And her A1C improvement is arguably more clinically significant than your weight loss in terms of long-term health outcomes.
[2] Wilding JPH, et al. N Engl J Med. 2021;384(11):989-1002.